Law ❯ Litigation ❯ Class Action ❯ Securities Litigation

Investor Rights

Securities Class Action Filed Against Zoetis Over Companion‑Animal Sales Decline

Plaintiffs allege company statements concealed weakening demand that culminated in a May 7, 2026 stock plunge and now investor firms are seeking lead plaintiffs under a July 27 deadline.

8 ARTICLES

2w ago

Securities Suits Pile Up After Verra Mobility’s Avis Termination and 70% Stock Crash

6 ARTICLES

last mo.

Securities Suit Filed Over Stellantis’ €22.2 Billion ‘Reset’ as Firms Race to Be Lead Plaintiff

7 ARTICLES

last mo.

Investors Vie to Lead ImmunityBio Securities Suit

7 ARTICLES

last mo.

Medpace Faces Securities Class Action Over Backlog Disclosures

3 ARTICLES

2mo ago

ImmunityBio Investors Face May 26 Deadline in Class Action After FDA Flags Misleading Anktiva Claims

6 ARTICLES

2mo ago

Law Firms Court Pinterest Investors to Lead Securities Suit Before May 29 Deadline

9 ARTICLES

2mo ago

Driven Brands Investors Face May 8 Lead‑Plaintiff Deadline as Firms Press SDNY Securities Case

3 ARTICLES

2mo ago

Pinterest Faces Securities Class Action as Lawyers Urge May 29 Lead‑Plaintiff Bids

4 ARTICLES

3mo ago

Driven Brands Investors Face May 8 Deadline in Securities Suit Over Accounting Restatements

3 ARTICLES

3mo ago

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

9 ARTICLES

3mo ago

Driven Brands Faces Securities Class Action in SDNY as Law Firms Rally Investors

5 ARTICLES

4mo ago

Law Firms Press Ardent Health Investors as March 9 Lead-Plaintiff Deadline Nears in Securities Case

7 ARTICLES

5mo ago

Varonis Investors Face March 9 Deadline to Lead Securities Class Action Over SaaS Conversion Claims

9 ARTICLES

5mo ago

Integer Investors Face Feb. 9 Deadline in Securities Class Action Over EP Demand Disclosures

9 ARTICLES

5mo ago

Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

6 ARTICLES

5mo ago

Agilon Health Investors Face March 2 Deadline in Competing Securities Class Actions

12 ARTICLES

5mo ago

Ardent Health Sued in Federal Securities Case Over Receivables and Malpractice Reserves Disclosures

9 ARTICLES

5mo ago

Varonis Sued in SDNY Securities Class Action Over SaaS Conversion Claims

8 ARTICLES

5mo ago

Lead‑Plaintiff Deadline Nears in Freeport‑McMoRan Securities Case

Investor Rights

Securities Class Action Filed Against Zoetis Over Companion‑Animal Sales Decline

Securities Suits Pile Up After Verra Mobility’s Avis Termination and 70% Stock Crash

Securities Suit Filed Over Stellantis’ €22.2 Billion ‘Reset’ as Firms Race to Be Lead Plaintiff

Investors Vie to Lead ImmunityBio Securities Suit

Medpace Faces Securities Class Action Over Backlog Disclosures

ImmunityBio Investors Face May 26 Deadline in Class Action After FDA Flags Misleading Anktiva Claims

Law Firms Court Pinterest Investors to Lead Securities Suit Before May 29 Deadline

Driven Brands Investors Face May 8 Lead‑Plaintiff Deadline as Firms Press SDNY Securities Case

Pinterest Faces Securities Class Action as Lawyers Urge May 29 Lead‑Plaintiff Bids

Driven Brands Investors Face May 8 Deadline in Securities Suit Over Accounting Restatements

Never miss stories about

Investor Rights

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

Driven Brands Faces Securities Class Action in SDNY as Law Firms Rally Investors

Law Firms Press Ardent Health Investors as March 9 Lead-Plaintiff Deadline Nears in Securities Case

Varonis Investors Face March 9 Deadline to Lead Securities Class Action Over SaaS Conversion Claims

Integer Investors Face Feb. 9 Deadline in Securities Class Action Over EP Demand Disclosures

Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

Agilon Health Investors Face March 2 Deadline in Competing Securities Class Actions

Ardent Health Sued in Federal Securities Case Over Receivables and Malpractice Reserves Disclosures

Varonis Sued in SDNY Securities Class Action Over SaaS Conversion Claims

Lead‑Plaintiff Deadline Nears in Freeport‑McMoRan Securities Case

Never miss stories about

Investor Rights